Kaposi sarcoma in people living with HIV: incidence and associated factors in the French DAT'AIDS cohort between 2010 and 2015.
Kaposi sarcoma (KS) is still observed among people living with HIV (PLHIV) including those on ART with undetectable HIV viral load (HIV-VL). We aimed to assess KS incidence and trends between 2010 and 2015 in France and to highlight associated factors. Retrospective study using longitudinal data from the Dat'AIDS cohort including 44 642 PLWH. For the incidence assessment, KS cases occurring within 30 days of cohort enrollment were excluded. Demographic, immunological, and therapeutic characteristics collected at time of KS diagnosis or at last visit for patients without KS. Among 180 216.4 person-years (PY), KS incidence was 76.0 [95% CI 64.3-89.9]/10 PY. Multivariate analysis (Poisson regression) revealed the positive association with male gender, men who have sex with men (MSM) transmission route, lower CD4 T cell count, higher CD8 T cell count, not to be on ART, while HIV follow-up time, duration with an HIV-VL≤50 copies/mL were negatively associated with KS. According to the different models tested, HIV-VL, CD4:CD8 ratio and nadir CD4 cell count were associated with KS. Moreover, stratified analysis showed that patients with a CD4:CD8 ratio≤0.5 or a CD8 T cell count>1000/mm were at higher risk of KS regardless of the CD4 T cell count. This study showed that in a resource-rich country setting with high ART coverage, KS still occurred among PLWH. CD8 hyperlymphocytosis and CD4:CD8 ratio should be now considered as two useful markers to better identify patients at increased KS risk, including those with a CD4 T cell count > 500/mm.